These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3055933)

  • 1. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.
    Finkelstein DM; Cassileth BR; Bonomi PD; Ruckdeschel JC; Ezdinli EZ; Wolter JM
    Am J Clin Oncol; 1988 Dec; 11(6):630-3. PubMed ID: 3055933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
    Bonomi PD; Finkelstein DM; Ruckdeschel JC; Blum RH; Green MD; Mason B; Hahn R; Tormey DC; Harris J; Comis R
    J Clin Oncol; 1989 Nov; 7(11):1602-13. PubMed ID: 2553879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
    Ruckdeschel JC; Finkelstein DM; Ettinger DS; Creech RH; Mason BA; Joss RA; Vogl S
    J Clin Oncol; 1986 Jan; 4(1):14-22. PubMed ID: 3510278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
    Finkelstein DM; Ettinger DS; Ruckdeschel JC
    J Clin Oncol; 1986 May; 4(5):702-9. PubMed ID: 3701389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).
    Ruckdeschel JC; Day R; Weissman CH; Stolbach LL; Creech RH
    Cancer Treat Rep; 1984 Nov; 68(11):1325-9. PubMed ID: 6388831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer.
    Thongprasert S; Sanquanmitr P
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():226-9. PubMed ID: 7661587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.
    Remick SC; McSharry JJ; Wolf BC; Blanchard CG; Eastman AY; Wagner H; Portuese E; Wighton T; Powell D; Pearce T
    J Clin Oncol; 1993 Sep; 11(9):1691-702. PubMed ID: 8355036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.
    Eagan RT; Frytak S; Richardson RL; Creagan ET; Therneau TM; Coles DT; Jett JR
    J Clin Oncol; 1988 Jan; 6(1):5-8. PubMed ID: 2826714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer.
    Thongprasert S; Soorraritchingchai S; Chewaskulyong B; Charoentum C; Munprakan S
    J Med Assoc Thai; 2006 Feb; 89(2):152-9. PubMed ID: 16579000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in lung cancer surgical adjuvant trials.
    Ruckdeschel JC; Piantadosi S
    Chest; 1994 Dec; 106(6 Suppl):324S-328S. PubMed ID: 7988255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiation and drug therapy of prostatic cancer].
    Matveev BP; Makarova GV; Bukharkin BV
    Urol Nefrol (Mosk); 1986; (3):65-72. PubMed ID: 3090758
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
    Niell HB; Griffin JP; West WH; Neely CL
    Cancer; 1984 Oct; 54(7):1260-3. PubMed ID: 6088022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
    Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
    Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
    Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso R
    Anticancer Res; 1990; 10(6):1743-5. PubMed ID: 2126683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
    Viallet J; Ihde DC
    J Clin Oncol; 1989 Aug; 7(8):985-7. PubMed ID: 2547029
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
    Walther PJ
    Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
    [No Abstract]   [Full Text] [Related]  

  • 18. The case for mitomycin in non-small cell lung cancer.
    Spain RC
    Oncology; 1993 Apr; 50 Suppl 1():35-50. PubMed ID: 8387177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index--cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30).
    King MT; Dobson AJ; Harnett PR
    J Clin Epidemiol; 1996 Jan; 49(1):21-9. PubMed ID: 8598507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide.
    Jones AL; Holborn J; Ashley S; Smith IE
    Eur J Cancer; 1991; 27(7):866-70. PubMed ID: 1657078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.